Abstract
Mycobacteria are important causes of head and neck infections. Mycobacterial lymphadenitis may be caused by both Mycobacterium tuberculosis and a variety of nontuberculous myocbacteria. Changes in the epidemiology of tuberculosis have caused a shift of the peak age range of tuberculous lymphadenitis from childhood to ages 20 to 40 years. Short-course chemotherapy is highly effective. Mycobacterium avium has become the most common cause of nontuberculous lymphadenitis, but new mycobacterial species are increasingly recognized. Treatment consists primarily of complete surgical excision, although roles for antimycobacterial chemotherapy are being identified. Transient flares of mycobacterial lymphadenitis, which occur during initiation of antituberculous therapy and in HIV-infected patients after initiation of antiretroviral therapy, may respond to short courses of corticosteroids. Tuberculous otitis media has become uncommon. Otitis media due to nontuberculous mycobacterial infection is increasingly seen in patients with pre-existing ear disease and after surgical and otic interventions. Tuberculosis of the eye has also become uncommon but may occur via hematogenous dissemination or direct innoculation. Nontuberculous mycobacteria, most commonly Mycobacterium chelonae and Mycobacterium fortuitum, may cause keratitis, usually after some form of corneal trauma.
Similar content being viewed by others
References and Recommended Reading
Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morbid Mortal Wkly Rep 1998, 47(RR-20):1–58.
Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. MMWR Morbid Mortal Wkly Rep 2000, 49:185–189.
Perlman DC, El-Helou P, Salomon N: Tuberculosis in patients with human immunodeficiency virus infection. Semin Respir Infect 1999, 14:344–352.These articles summarize recent clinical developments in and recommendations for the management of HIV-related tuberculosis.
Artenstein AW, Kim JH, Willimas WJ, et al.: Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clin Infect Dis 1995, 20:876–882.
Kourbeti IS, Maslow MJ: Nontuberculous mycobacterial infections of the lung. Curr Infect Dis Rep 2000, 2:193–200.This paper provides an excellent summary of the epidemiology, microbiology, and treatment of NTM infections.
van Loenhout-Rooyackers JH, Laheij RJ, Richter C, et al.: Shortening the duration of treatment for cervical tuberculous lymphadenits. Eur Respir J 2000, 15:192–195.
Diagnosis and treatment of disease caused by nontuberculous mycobacteria. American Thoracic Society. Am J Respir Crit Care Med 1997, 156:S1–S25.
Yuen AP, Wong SH, Tam CM, et al.: Prospective randmonized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy. Otolaryngol Head Neck Surg 1997, 116:189–192.
Campbell IA: The treatment of superficial tuberculous lymphadenitis. Tubercle 1990, 71:1–3.
Hill AR, Mateo F, Hudak A: Transient exacerbation of tuberculous lymphadenitis during chemotherapy in patients with AIDS. Clin Infect Dis 1994, 19:774–776.
Phillips P, Kwiatkowski MB, Copland M, et al.: Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy. J AIDS 1999, 20:122–128.This paper characterizes a recently described immune reconstitution syndrome in which mycobacterial lymphadenitis develops after the initiation of highly active antiretroviral therapy.
Girardi E, Antonucci G, Vanacore P, et al.: Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 2000, 14:1985–1991.This report documents the beneficial impact of combination antiretroviral therapy on tuberculosis risk among HIV-infected persons.
Jana N, Vasishta K, Saha SC, et al.: Obstetrical outcomes among women with extrapulmonary tuberculosis. N Engl J Med 1999, 341:645–649.
Lind A, Larsson LO, Bentzon MW, et al.: Sensitivity to sensitins and tuberculin in Swedish children. I. A study of schoolchildren in an urban area. Tubercle 1991, 72:29–36.
Trinka L, Dankova D, Svandova E: Six years’ experience with the discontinuation of BCG vaccination. IV. Protective effect of BCG vaccination against Mycobacterium avium intracelluare complex. Tubercle Lung Dis 1994, 75:348–352.
Oguz F, Mujgan S, Alper G, et al.: Treatment of bacillus Calmette-Guerin-associated lymphadenitis. Pediatr Infec Dis J 1992, 11:887.
Wolinsky E: Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long term follow-up. Clin Infect Dis 1995, 20:954–963.
von Reyn CF, Williams DE, Horsburgh CR Jr, et al.: Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis 1998, 177:730–736.
Singh K, Muralidar M, Kumar A, et al.: Comparison of in house polymerase chain reaction techniques for the detection of Mycobacterium tuberculosis DNA in granulomatous lymphadenopathy. J Clin Pathol 2000, 53:355–361.
Frevel T, Schafer KL, Totsch M, et al.: PCR based detection of mycobacteria in parrafin wax embedded material routinely processed for morphologic examination. J Clin Pathol 1999, 52:283–288.
Robson CD, Hazra R, Barnes PD, et al.: Nontuberculous mycobacterial infection of the head and neck in immunocompetent children: CT and MR findings. Am J Neuroradiol 1999, 20:1829–1835.
Hazra R, Robson CD, Perez-Atayde AR, et al.: Lymphadenitis due to nontuberculous mycobacteria in children: presentation and response to therapy. Clin Infect Dis 1999, 28:123–129.This series nicely outlines the presentation of NTM in children and provides a useful overview of its therapy.
Moon WK, Han MH, Chang KH, et al.: CT and MR imaging of head and neck tuberculosis. Radiographics 1997, 17:391–402.
Tunkel DE: Surgery for cervicofacial nontuberculous mycobacterial adenitis in children. Arch Otoloryngol Head Neck Surg 1999, 125:1109–1113.This article addresses issues in the surgical management of NTM lyphadenitis in children.
Losurrdo G, Castagnola E, Cristina E, et al.: Cervical lymphadenitis caused by nontuberculous mycobacteria in immunocompetent children: clinical and therapeutic experience. Head Neck 1998, 20:245–249.This article also addesses issues in the surgical management of NTM lymphadenitis in children.
Correa AG, Startke JR: Nontuberculous mycobacterial disease in children. Semin Respir Infect 1996, 11:262–271.
Henriques B, Hoffner SE, Petrini B, et al.: Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis 1994, 18:596–600.
Springer B, Kirschner P, Rost-Meyer G, et al.: Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis. J Clin Microbiol 1993, 31:3083–3089.
Haase G, Kentrup H, Skopnik H, et al.: M. lentiflavum: an etiologic agent of cervical lymphadenitis. Clin Infect Dis 1997, 25:1245.
Haas WH, Butler WR, Kirschener P, et al.: A new agent of mycobacterial lymphadenitis in children, M. heidelbergense sp. Nov. J Clin Micobiol 1997, 35:3202.
Bosquee L, Bottger EC, De Beenhouwer H, et al.: Cervical lymphadenitis caused by a fastidious mycobacterium closely related to Mycobacterium genavense in an apparently immunocompetent woman: diagnosis by culture-free microbiological methods. J Clin Microbiol 1995, 33:2670–2674.
Hermon-Taylor J, Barnes N, Clarke C, et al.: Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn’s disease. BMJ 1998, 316:449–453.
Kirsch CM, Wehner JH, Jensen WA: Tuberculosis otitis media. South Med J 1995, 88:363–366.
Singh B: Role of surgery in tuberculous mastoiditis. J Laryngol Otol 1991, 105:907–915.
Narambhai RC, Mathiassen W, Malan AF: Congenital tuberculosis localized to the ear. Arch Dis Child 1989, 64:738–740.
Skolnik PR, Nadol JB, Baker AS: Tuberculosis of the middle ear: review of the literature with an instructive case report 1986. Rev Infect Dis 1986, 8:403–410.
Ikeda IT, Sato KT, Iketa NK, et al.: A case of middle ear tuberculosis: PCR of the otorrhea was useful for the diagnosis. Kekkaku 1999, 74:453–456.
Franklin DJ, Starke JR, Brady MT, et al.: Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity. Am J Otol 1994, 15:313–320.
Stewart MG, Troendle-Atkins J, Starke J: Nontuberculous mycobacterial mastoidtis. Arch Otolaryngol Head Neck Surg 1995, 121:225–228.
Bouza E, Merino P, Munoz P, et al.: Ocular tuberculosis, a prospective study in a general hospital. Medicine (Baltimore) 1997, 76:53–61.
Chang WJ, Tse DT, Rosa RH. Jr, et al.: Periocular atypical mycobacterial infections. Ophthalmology 1999, 106:86–90.
Khalil M, Lindley S, Matouk E: Tuberculosis of the orbit. Ophthalmology 1985, 92:1624–1627.
Helm CJ, Holland GN: Ocular tuberculosis. Surv Ophthalmol 1993, 38:229–256.
D’Souza P, Garg R, Dhaliwal RS, et al.: Orbital-tuberculosis. Int Ophthalmol 1994, 18:149–152.
Albert DM, Dehm E: Ocular tuberculosis. In Tuberculosis, edn 3. Edited by Schlossberg D. New York: Springer-Verlag; 1994:119–128.
Henderly DE, Genstler AJ, Smith RE, et al.: Changing patterns of uveitis. Am J Ophthalmol 1987, 103:131–136.
Reny JL, Challe G, Geisert P, et al.: Tuberculosis-related retinal vasculitis in an immunocompetent patient. Clin Infect Dis 1996, 22:873–974.
Dugel PU, Holland GN, Brown HH, et al.: Mycobacterium fortuitum keratitis. Am J Ophthalmol 1988, 105:661–669.
Geleneder H, Carter HL, Bowman B, et al.: Mycobacterium keratitis after laser in situ keratomileusis. J Refractive Surg 2000, 16:191–195.
Ramaswamy AA, Biswas J, Bhaskar V, et al.: Post operative Mycobacterium chelonae endophthalmitis after extracapsular cataract extraction and posterior chamber intraocular lens implantation. Ophthalmology 2000, 107:1283–1286.
Brown BA, Wallace RJ, Onyi GO, et al.: Activities of four macrolides including clarithromycin against Mycobacterium fortutium, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992, 36:180–184.
Hu F-R, Luh K-T: Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis. Ophthalmology 1998, 105:269–272.
He FR, Wang IJ: Comparison of topical antibiotics for treating Mycobacterium chelonae keratitis in a rabbit model. Curr Eye Res 1998, 17:478–482.
Wallace RJ Jr, Bedsole G, Sumter G, et al.: Activity of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single drug therapy. Antimicrob Agents Chemother 1990, 34:65–70.
Outman WR, Levitz RE, Hill DA, et al.: Intraocular penetration of rifampin in humans. Antimicrob Agents Chemother 1992, 36:1575–1576.
Baum J: Infections of the eye. Clin Infect Dis 1995, 21:479–488.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perlman, D.C., D’Amico, R. & Salomon, N. Mycobacterial infections of the head and neck. Curr Infect Dis Rep 3, 233–241 (2001). https://doi.org/10.1007/s11908-001-0025-4
Issue Date:
DOI: https://doi.org/10.1007/s11908-001-0025-4